Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models

Loss of GPR3 reduced amyloid plaque burden and improved cognition in four mouse models of Alzheimer’s disease, suggesting that GPR3 may be a potential therapeutic target.